Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson’s disease - Schwarz, J; Antonini, A; Kraft, E; Tatsch, K; Vogl, T; Kirsch, CM; Leenders, KL; Oertel, WH (Neurology, 1994)